Growing community of inventors

Prague, Czechia

Milan Dejmek

Average Co-Inventor Count = 6.78

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 25

Milan DejmekRichard L Mackman (4 patents)Milan DejmekPetr Jansa (4 patents)Milan DejmekYunfeng Eric Hu (4 patents)Milan DejmekEric Lansdon (4 patents)Milan DejmekOndrej Baszczynski (4 patents)Milan DejmekPetr Simon (4 patents)Milan DejmekOndrej Pav (1 patent)Milan DejmekGabriel Birkus (1 patent)Milan DejmekRadim Nencka (1 patent)Milan DejmekMichal Sala (1 patent)Milan DejmekPetra Brehova (1 patent)Milan DejmekRadim Nencka (1 patent)Milan DejmekTomas Otava (0 patent)Milan DejmekPetr Jansa (1 patent)Milan DejmekGabriel Birkus (0 patent)Milan DejmekMilan Dejmek (5 patents)Richard L MackmanRichard L Mackman (94 patents)Petr JansaPetr Jansa (27 patents)Yunfeng Eric HuYunfeng Eric Hu (16 patents)Eric LansdonEric Lansdon (7 patents)Ondrej BaszczynskiOndrej Baszczynski (4 patents)Petr SimonPetr Simon (4 patents)Ondrej PavOndrej Pav (6 patents)Gabriel BirkusGabriel Birkus (6 patents)Radim NenckaRadim Nencka (3 patents)Michal SalaMichal Sala (3 patents)Petra BrehovaPetra Brehova (2 patents)Radim NenckaRadim Nencka (1 patent)Tomas OtavaTomas Otava (0 patent)Petr JansaPetr Jansa (3 patents)Gabriel BirkusGabriel Birkus (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Gilead Sciences, Inc. (4 from 924 patents)

2. Institute of Organic Chemistry and Biochemistry of the As Cr, V.v.i. (4 from 7 patents)

3. Institute of Organic Chemistry and Biochemistry Ascr, V.v.i. (1 from 14 patents)


5 patents:

1. 11766447 - 3'3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator

2. 11304948 - Quinazoline compounds

3. 10548898 - Quinazoline compounds

4. 10206926 - Quinazoline compounds

5. 9730936 - Quinazoline compounds

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…